Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas

Oral Oncology

Volumn 40, Issue 5, 2004, Pages 520-524

  Hoffmann, Markus ^a   Lohrey, Claudia ^b   Hunziker, Andreas ^b   Kahn, Tomas ^b,c   Schwarz, Elisabeth ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c DEUTSCHE BANK AG   (Germany)

Author keywords

Carcinogenesis; E6; E7; Head and neck squamous carcinoma; HPV16 variant; Human papillomavirus; Oncogene

Indexed keywords

PROTEIN E6; PROTEIN E7; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE DISRUPTION; GENE SEQUENCE; GENOMICS; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; DNA, VIRAL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS;

EID: 1542360067     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.10.011     Document Type: Article

References (19)

1. Gillison M.L., Shah K.V. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr. Opin. Oncol. 13(3):2001;183-188.
2. Paz I.B., Cook N., Odom-Maryon T., Xie Y., Wilczynski S.P. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer. 79(3):1997;595-604.
3. Andl T., Kahn T., Pfuhl A., Nicola T., Erber R., Conradt C.et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 58(1):1998;5-13.
4. Hoffmann M., Kahn T., Mahnke C.G., Goeroegh T., Lippert B.M., Werner J.A. Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta. Otolaryngol. (Stockh.). 118:1998;138-144.
5. Hoffmann et al., in preparation.
6. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L.et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92(9):2000;709-720.
7. Mellin H., Friesland S., Lewensohn R., Dalianis T., Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int. J. Cancer. 89(3):2000;300-304.
8. Klussmann J.P., Weissenborn S.J., Wieland U., Dries V., Kolligs J., Jungehuelsing M.et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer. 92(11):2001;2875-2884.
9. Li W., Thompson C.H., O'Brien C.J., McNeil E.B., Scolyer R.A., Cossart Y.E.et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int. J. Cancer. 106(4):2003;553-558.
10. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer. 2(5):2002;342-350.
11. Wiest T., Schwarz E., Enders C., Flechtenmacher C., Bosch F.X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene. 21:2002;1510-1517.
12. van Houten V.M., Snijders P.J., van den Brekel M.W., Kummer J.A., Meijer C.J., van Leeuwen B.et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int. J. Cancer. 93(2):2001;232-235.
13. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X.et al. Human papillomavirus type 16 sequence variations in cervical cancers: a worldwide perspective. J. Virol. 71(3):1997;2463-2472.
14. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V.et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:1999;12-19.
15. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58(4):1998;829-833.
16. Zehbe I., Tachezy R., Mytilineos J., Voglino G., Mikyskova I., Delius H.et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int. J. Cancer. 94(5):2001;711-716.
17. Kämmer C., Tommasino M., Syrjanen S., Delius H., Hebling U., Warthorst U.et al. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br. J. Cancer. 86(2):2002;269-273.
18. Ellis J.R., Keating P.J., Baird J., Hounsell E.F., Renouf D.V., Rowe M. et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1(5):1995;464-470.
19. Etherington I.J., Ellis J.R., Luesley D.M., Moffitt D.D., Young L.S. Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol. Oncol. 72(1):1999;56-59.